Medtronic PLC is a global leader in medical technology, dedicated to alleviating pain, restoring health, and extending life for patients worldwide. The company's mission is to contribute to human welfare by applying biomedical engineering to the diagnosis, treatment, and monitoring of health conditions. Medtronic's strategy focuses on innovation and collaboration, developing advanced medical devices and therapies across various sectors, including cardiovascular, diabetes, and neurological care. With a commitment to improving patient outcomes, Medtronic operates in over 150 countries, leveraging cutting-edge technology and research to enhance healthcare delivery and accessibility.

MEDTRONIC PLC

Medtronic reported its fiscal year 2025 Q3 earnings, with shares plummeting over 7% to around $86 per share, positioning the company’s market capitalization at approximately $110 billion. This significant drop follows a revenue miss where the company reported $8.3 billion in net revenue—a mere 2.5% increase that fell short of...

Medtronic Faces 7% Stock Decline Amid Mixed Q3 Earnings and Increased Competition in Diabetes Market

Medtronic's recent Q3 earnings reveal a mixed bag, with a 7% stock decline despite a resilient diabetes segment showing nearly 10.5% revenue growth. As competition intensifies from new weight-loss drugs, can Medtronic leverage its innovation and strong cash flow to navigate these challenges?